Oriola Oyj (LON:0NES)

Market Cap	194.58M
Revenue (ttm)	1.55B
Net Income (ttm)	-26.40M
Shares Out	n/a
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	21.11
Dividend	0.06 (5.05%)
Ex-Dividend Date	Apr 3, 2025

Volume	3,414
Average Volume	9,783
Open	1.220
Previous Close	1.213
Day's Range	1.216 - 1.220
52-Week Range	0.877 - 1.218
Beta	0.59
RSI	67.07
Earnings Date	Oct 30, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial numbers in EUR